$ICPT News Drug companies Salix, Intercept reeling

New Post Public Reply Private Reply Replies (0) Message Board

Nov 16, 2014 at 1:53 PM

$ICPT News

Drug companies Salix, Intercept reeling after earnings, drama 12:15 p.m. Nov. 7, 2014 - Russ Britt
10 Nasdaq stocks with returns of at least 240% in 2014 4:38 p.m. Sept. 11, 2014 - Philip van Doorn
U.S. stocks end lower; Dow turns negative for the year 3:06 p.m. Aug. 12, 2014 - Anora Mahmudova
Skullcandy gains on upgrade,Tesla reverses gains 1:37 p.m. Aug. 12, 2014 - Sue Chang
Two drug makers diverge in Wall Street woods, and see huge moves 10:31 a.m. Aug. 12, 2014 - Russ Britt
Intercept shares surge after releasing positive liver drug data 7:04 a.m. Aug. 12, 2014 - Peter Loftus
Biotech hammered as ETFs down 5%, while some stocks fall 10% 12:55 p.m. April 10, 2014 - Russ Britt
Is biotech caught in a bubble, and is it popping? 12:13 p.m. April 8, 2014 - Russ Britt
Intercept investors see glass half empty as stock falls on drug news 3:32 p.m. March 17, 2014 - Russ Britt
This shocking strategy will save your portfolio 6:01 a.m. Jan. 15, 2014 - Jeff Reeves
Alnylam shares settle down after 40% gain; analysts are skeptical 1:16 p.m. Jan. 14, 2014 - Russ Britt
Intercept, Intuitive take diverging paths on the market roller coaster 10:51 a.m. Jan. 14, 2014 - Russ Britt
Dow industrials suffer worst drop since Sept. 20: Stock market live blog recap 4:41 p.m. Jan. 13, 2014 - blogs.marketwatch.com
Beam up on Suntory deal; Elliott report lifts Juniper 4:18 p.m. Jan. 13, 2014 - Sue Chang
Merck shares hit 52-week high on drug hopes, plans for cutbacks 12:31 p.m. Jan. 13, 2014 - Russ Britt
Intercept, Lululemon, SodaStream shares slump 10:22 a.m. Jan. 13, 2014 - Saumya Vaishampayan
S&P 500 gains for week; builder stocks rally as yields fall; the wonder of liver-drug stocks (live blog recap) 10:15 a.m. Jan. 13, 2014 - blogs.marketwatch.com
Clovis Oncology, seen as 'next ICPT,' jumps 5% 9:47 a.m. Jan. 13, 2014 - Victor Reklaitis
Intercept shares trip short-sale circuit breaker 9:32 a.m. Jan. 13, 2014 - Laura Mandaro
Intercept, Celgene on move amid J.P. Morgan event 9:20 a.m. Jan. 13, 2014 - Victor Reklaitis

Biotech Stock Mailbag: Spectrum, Intercept, Orexigen, Amarin, MannKind 6:00 a.m. Nov. 14, 2014 - TheStreet.com
Intercept Pharmaceuticals Slumps: ICPT Falls 5.9% in Session - Tale of the Tape 8:34 a.m. Nov. 13, 2014 - Zacks.com
Intercept Pharmaceuticals (ICPT) Is Weak On High Volume Today 10:00 a.m. Nov. 12, 2014 - TheStreet.com
Intercept Pharmaceuticals (ICPT) Downgraded From Hold to Sell 9:21 a.m. Nov. 12, 2014 - TheStreet.com
Intercept Pharmaceuticals' (ICPT) AASLD Investor Event - Transcript 1:54 p.m. Nov. 11, 2014 - Seeking Alpha
Conatus Pharmaceuticals (CNAT): Will Loss Narrow in Q3? - Analyst Blog 1:50 p.m. Nov. 11, 2014 - Zacks.com
Intercept Pharmaceuticals' Shares Crash on FLINT Results - Analyst Blog 5:03 p.m. Nov. 10, 2014 - Zacks.com
Intercept Seen as Poster-boy for Possible Biotech Bubble 2:58 p.m. Nov. 10, 2014 - TheStreet.com
Biotech Weekly: When Mid Caps Are Priced Nearly For Perfection 10:28 a.m. Nov. 10, 2014 - Seeking Alpha
Intercept Pharmaceuticals (ICPT) Marked As A Dead Cat Bounce Stock 9:48 a.m. Nov. 10, 2014 - TheStreet.com
Stock Movers: Why Medicals Issues Are Dipping Today 2:26 p.m. Nov. 7, 2014 - Investors Business Daily
Intercept Pharmaceuticals (ICPT) Trading With Heavy Volume Before Market Open 8:34 a.m. Nov. 7, 2014 - TheStreet.com
10-Q: INTERCEPT PHARMACEUTICALS INC 5:24 p.m. Nov. 6, 2014 - Edgar Online - (EDG = 10Q, 10K)
Will Intercept Pharmaceuticals' (ICPT) Q3 Loss Narrow? - Analyst Blog 4:02 p.m. Nov. 6, 2014 - Zacks.com
Meet The 5 Companies Loving Obamacare 7:04 p.m. Nov. 4, 2014 - Benzinga.com
The Time Is Now For Northwest Biotherapeutics 3:16 p.m. Oct. 29, 2014 - Seeking Alpha
3 Hot Ways to Play the Biotechnology Bonanza 6:36 a.m. Sept. 16, 2014 - InvestorPlace.com
Biotech Stocks With Upside Target Ebola, Liver Disease 6:30 a.m. Sept. 16, 2014 - InvestorPlace.com
Is Intercept Pharmaceuticals Building The Next Great Specialty Franchise? 2:30 p.m. Sept. 15, 2014 - Seeking Alpha
Biotechs With Upside Target Ebola And Liver Disease: MLV's Vernon Bernardino 9:16 a.m. Sept. 11, 2014 - Seeking Alpha

Intercept Announces Additional Data for OCA in Primary Biliary Cirrhosis 8:02 a.m. Nov. 8, 2014 - GlobeNewswire
FLINT Trial in NASH Published in The Lancet 7:06 p.m. Nov. 6, 2014 - GlobeNewswire
Intercept to Report Third Quarter 2014 Results on November 7 and Present at Upcoming Conferences 5:02 a.m. Oct. 31, 2014 - GlobeNewswire
Recognition, Product Enhancement, Marketing Approval, Upcoming Events, and Quarterly Earnings - Research Reports on Abbott, Illumina, Thermo Fisher, Intercept and Stryker 7:40 a.m. Oct. 22, 2014 - PR Newswire - PRF
Critical Alerts For Exxon Mobil, Celgene, Verizon, Intercept Pharmaceuticals and Lockheed Martin Released By InvestorsObserver 8:31 a.m. Oct. 8, 2014 - PR Newswire - PRF
Intercept Announces Data to be Presented at the 2014 AASLD Annual Meeting 5:30 a.m. Oct. 8, 2014 - GlobeNewswire
Quarterly Changes to the NASDAQ Q-50 Index 6:06 a.m. Sept. 15, 2014 - GlobeNewswire
Intercept Pharmaceuticals Recognizes International PBC Day 5:56 a.m. Sept. 12, 2014 - GlobeNewswire
Critical Alerts For Apple, Kinder Morgan, Stratasys, Intercept Pharmaceuticals and NPS Pharmaceuticals Released By InvestorsObserver 8:31 a.m. Sept. 8, 2014 - PR Newswire - PRF
Intercept to Present at Upcoming Investor Conferences 7:05 a.m. Aug. 26, 2014 - GlobeNewswire
Drug Approvals, Financial Results, Market Activity, New Mobile Applications, and Company Updates - Research Reports on Intercept, Exact Sciences, Thermo Fisher Scientific, Illumina and Agilent 8:00 a.m. Aug. 15, 2014 - PR Newswire - PRF
Critical Alerts For GoPro, Intercept Pharmaceuticals, Pixelworks, Vertex Pharmaceuticals and General Mills. Released By InvestorsObserver 8:31 a.m. Aug. 13, 2014 - PR Newswire - PRF
Intercept to Host Second Quarter 2014 Update on August 11 and Present at Upcoming Investor Conference 4:01 p.m. Aug. 4, 2014 - GlobeNewswire
Galectin, Intercept, Others Vying for Lead Drugs in NASH Epidemic 9:03 a.m. July 24, 2014 - ACCESSWIRE
Intercept Pharmaceuticals Names Lazar Partners Agency of Record 9:08 a.m. July 10, 2014 - Marketwire
Catalysts on the Horizon for Companies Developing NAFLD and NASH Drugs 8:42 a.m. June 26, 2014 - ACCESSWIRE
Conference Presentations, Settlement and License Agreement, New Leadership, and Start of Phase III Study - Analyst Notes on Alexion, Mylan, Novartis, GSK and Intercept 4:50 a.m. June 11, 2014 - PR Newswire - PRF
FDA Approvals, Digital Health Guidance, Conference Presentations, and Recognitions - Analyst Notes on Intercept Pharmaceuticals, Cigna, Baxter, Questcor and Mallinckrodt 6:00 a.m. June 3, 2014 - PR Newswire - PRF
Technical Coverage of Health Care Sector Equities -- Research on Intercept Pharma, ACADIA Pharma, DENTSPLY Intl., and OraSure Technologies 10:42 a.m. May 15, 2014 - PR Newswire - PRF
Wall Street In and Out of Love with NASH Drug Developers 9:21 a.m. May 13, 2014 - ACCESSWIRE

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Countries Eye New Investment Paths at CIFIT 2026

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

Larry Ellison's Moves Signal Confidence in Oracle's Future

Unraveling Ellison's Bold Decision There's nothing like a sudden shift from a tech titan to make Wall Street sit up and take notice. Today, we got the word that Larry Ellison, Oracle's big gun as Executive Chair and CTO, has pulled the plug on his plan to sell Oracle stock. No dice, no distance covered under that plan. And he's made it crystal clear—selling isn't on his...

ARTiSTORY's Strategic Advance in Cultural IP Licensing

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

New 2027 Jeep Wrangler JL-2A: A Blast from the Past

Revisiting a Prized Legacy: The 2027 Jeep Wrangler JL-2A Sometimes, what’s new is really just a nod to what’s old—and nowhere is this more so than with the 2027 Jeep Wrangler JL-2A. In the grand parade of automotive history, Jeep's latest creation is more than just a vehicle; it's a time machine that cruises on its historic lineage while strapping on all the modern...

Damp or Dry: The Battle for Healthy Air in Colorado

The Hidden Cost of Colorado's Dry Air Dry climate isn't just a seasonal inconvenience—it's a real hidden cost to living comfortably and healthily in Colorado. With winters colder than a brass monkey's tail and summers that don't offer much relief in terms of humidity, your home's air quality is on the front line. So, what's the financial tale here, and how do you come...

OneOdio Showcases Innovation at IFA 2026 in Berlin

Echoes from Berlin IFA 2026 in Berlin was a cacophony of innovation, as OneOdio wrapped up its showcase with a bang. Boasting interactive activities and live DJ sets, the event echoed OneOdio's drive to meld advanced audio technology with the pulsating needs of music pros and everyday listeners. You couldn’t miss the excitement in the air at Booth 217. Tech Unplugged:...

U.S. Green Beret's Mission: Clearing Landmines in Ukraine

The Rise of "Safe Ground" on Prime Video This isn't your typical feel-good story—it’s about grit and the unending fight for 'normalcy' where war left scars. Safe Ground, now streaming on Prime Video, showcases Ryan Hendrickson, a U.S. Army Green Beret whose story takes a sharp turn after stepping on an IED in 2010. The day he almost became just another statistic...

SMPL Faces Legal Drama: What Investors Need to Know

Investors Swim Against the Current With SMPL Picture this: You’re sipping your morning coffee, glancing through stocks, only to choke on your bagel when The Simply Good Foods Company (NASDAQ: SMPL) pops up with some less-than-palatable news. A class action is brewing, shouting out to investors who took the bait from October 24, 2024, to April 8, 2026. If you’re one of...

PathoSearch: A New Era in Pathology With Visual Search

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

D-Wave Faces Legal Questions After CFO Exit and Losses

Trouble Brews at D-Wave Quantum Smack in the middle of market chaos, D-Wave Quantum Inc. (NASDAQ: QBTS) seems to have hit a rather gnarly pothole. With disappointing revenue figures for Q2 of 2026—coming in at a measly $3.08 million, far below the expected range of $4.03 million to $4.08 million—investors have more than enough reasons to be irked. When the numbers...